• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

NF-κB 信号通路相关长非编码 RNA 与宫颈癌肿瘤微环境和预后的关联。

The linkage of NF-κB signaling pathway-associated long non-coding RNAs with tumor microenvironment and prognosis in cervical cancer.

机构信息

Department of Reproductive Medicine, The First Affiliated Hospital of Harbin Medical University, Harbin, 150010, China.

Department of Medical Psychology, Harbin Medical University, Harbin, 150010, China.

出版信息

BMC Med Genomics. 2023 Jul 17;16(1):169. doi: 10.1186/s12920-023-01605-9.

DOI:10.1186/s12920-023-01605-9
PMID:37461017
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10351132/
Abstract

BACKGROUND

NF-κB signaling pathway participate closely in regulating inflammation and immune response in many cancers. Long non-coding RNAs (lncRNAs) associated with NF-κB signaling have not been characterized in cervical cancer. This study revealed the linkage between tumor microenvironment and NF-κB signaling-associated lncRNAs in cervical cancer.

MATERIALS AND METHODS

The expression profiles of cervical cancer samples from The Cancer Genome Atlas (TCGA) database were downloaded. NF-κB signaling-associated lncRNAs were screened as a basis to perform molecular subtyping. Immune cell infiltration was assessed by ESTIMATE, Microenvironment Cell Populations (MCP)-counter and single sample gene set enrichment analysis (ssGSEA). The key NF-κB signaling-associated lncRNAs were identified by univariate analysis, least absolute shrinkage and selection operator, and stepAIC.

RESULTS

Three molecular subtypes or clusters (cluster 3, cluster 2, and cluster 1) were categorized based on 27 prognostic NF-κB signaling-associated lncRNAs. Cluster 2 had the worst prognosis, highest immune infiltration, as well as the highest expression of most of immune checkpoints. Three clusters showed different sensitivities to immunotherapy and chemotherapy. Six key NF-κB signaling-associated lncRNAs were screened to establish a six-lncRNA risk model for predicting cervical cancer prognosis.

CONCLUSIONS

NF-κB signaling-associated lncRNAs played an important role in regulating immune microenvironment. The subtyping based on NF-κB signaling-associated lncRNAs may assist in the selection of optimal treatments. The six key NF-κB signaling-associated lncRNAs could act as prognostic biomarkers in prognostic prediction for cervical cancer.

摘要

背景

NF-κB 信号通路在许多癌症中密切参与调控炎症和免疫反应。与 NF-κB 信号相关的长非编码 RNA(lncRNA)在宫颈癌中尚未得到描述。本研究揭示了宫颈癌中肿瘤微环境与 NF-κB 信号相关 lncRNA 之间的联系。

材料与方法

从癌症基因组图谱(TCGA)数据库下载宫颈癌样本的表达谱。筛选与 NF-κB 信号相关的 lncRNA 作为进行分子亚型分析的基础。通过 ESTIMATE、Microenvironment Cell Populations(MCP)-counter 和单样本基因集富集分析(ssGSEA)评估免疫细胞浸润。通过单变量分析、最小绝对值收缩和选择算子(least absolute shrinkage and selection operator,LASSO)和 stepAIC 鉴定关键 NF-κB 信号相关 lncRNA。

结果

基于 27 个与 NF-κB 信号相关的预后 lncRNA,将三个分子亚型或簇(cluster 3、cluster 2 和 cluster 1)进行分类。cluster 2 预后最差,免疫浸润最高,大多数免疫检查点表达也最高。三个簇对免疫治疗和化疗的敏感性不同。筛选出六个关键的 NF-κB 信号相关 lncRNA 以建立预测宫颈癌预后的六 lncRNA 风险模型。

结论

NF-κB 信号相关 lncRNA 在调节免疫微环境中发挥重要作用。基于 NF-κB 信号相关 lncRNA 的分型可能有助于选择最佳治疗方案。这六个关键的 NF-κB 信号相关 lncRNA 可作为宫颈癌预后预测的预后标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4a7/10351132/728cbcf5f096/12920_2023_1605_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4a7/10351132/545d0c2a63fa/12920_2023_1605_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4a7/10351132/705514656e13/12920_2023_1605_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4a7/10351132/329a7c05fe27/12920_2023_1605_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4a7/10351132/4aa462bad765/12920_2023_1605_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4a7/10351132/732d94e6e047/12920_2023_1605_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4a7/10351132/658d945a4a68/12920_2023_1605_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4a7/10351132/aac574b9a5be/12920_2023_1605_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4a7/10351132/728cbcf5f096/12920_2023_1605_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4a7/10351132/545d0c2a63fa/12920_2023_1605_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4a7/10351132/705514656e13/12920_2023_1605_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4a7/10351132/329a7c05fe27/12920_2023_1605_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4a7/10351132/4aa462bad765/12920_2023_1605_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4a7/10351132/732d94e6e047/12920_2023_1605_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4a7/10351132/658d945a4a68/12920_2023_1605_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4a7/10351132/aac574b9a5be/12920_2023_1605_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4a7/10351132/728cbcf5f096/12920_2023_1605_Fig8_HTML.jpg

相似文献

1
The linkage of NF-κB signaling pathway-associated long non-coding RNAs with tumor microenvironment and prognosis in cervical cancer.NF-κB 信号通路相关长非编码 RNA 与宫颈癌肿瘤微环境和预后的关联。
BMC Med Genomics. 2023 Jul 17;16(1):169. doi: 10.1186/s12920-023-01605-9.
2
Oncogenic signaling pathway-related long non-coding RNAs for predicting prognosis and immunotherapy response in breast cancer.用于预测乳腺癌预后和免疫治疗反应的致癌信号通路相关长链非编码RNA
Front Immunol. 2022 Aug 4;13:891175. doi: 10.3389/fimmu.2022.891175. eCollection 2022.
3
N6-Methyladenosine-Related lncRNAs as potential biomarkers for predicting prognoses and immune responses in patients with cervical cancer.N6-甲基腺苷相关长链非编码 RNA 作为预测宫颈癌患者预后和免疫反应的潜在生物标志物。
BMC Genom Data. 2022 Jan 18;23(1):8. doi: 10.1186/s12863-022-01024-2.
4
Comprehensive analysis of tumor immune microenvironment and prognosis of m6A-related lncRNAs in gastric cancer.胃癌中 m6A 相关 lncRNAs 的肿瘤免疫微环境综合分析与预后评估。
BMC Cancer. 2022 Mar 24;22(1):316. doi: 10.1186/s12885-022-09377-8.
5
The necroptosis-related signature and tumor microenvironment immune characteristics associated with clinical prognosis and drug sensitivity analysis in stomach adenocarcinoma.与胃腺癌临床预后及药物敏感性分析相关的坏死性凋亡相关特征及肿瘤微环境免疫特征
Aging (Albany NY). 2024 Mar 27;16(7):6098-6117. doi: 10.18632/aging.205690.
6
Integrated analysis of N6-methyladenosine- and 5-methylcytosine-related long non-coding RNAs for predicting prognosis in cervical cancer.N6-甲基腺苷和 5-甲基胞嘧啶相关长非编码 RNA 的综合分析用于预测宫颈癌的预后。
Hereditas. 2024 Sep 16;161(1):34. doi: 10.1186/s41065-024-00336-w.
7
Immune checkpoints related-LncRNAs can identify different subtypes of lung cancer and predict immunotherapy and prognosis.免疫检查点相关长链非编码 RNA 可鉴定不同亚型的肺癌,并预测免疫治疗和预后。
J Cancer Res Clin Oncol. 2022 Jul;148(7):1597-1612. doi: 10.1007/s00432-022-03940-3. Epub 2022 Mar 17.
8
Predicting Prognosis and Distinguishing Cold and Hot Tumors in Bladder Urothelial Carcinoma Based on Necroptosis-Associated lncRNAs.基于坏死性细胞凋亡相关 lncRNAs 预测膀胱癌预后和鉴别冷肿瘤和热肿瘤。
Front Immunol. 2022 Jul 4;13:916800. doi: 10.3389/fimmu.2022.916800. eCollection 2022.
9
Development of a novel hypoxia-immune-related LncRNA risk signature for predicting the prognosis and immunotherapy response of colorectal cancer.开发一种新型的缺氧免疫相关 LncRNA 风险签名,用于预测结直肠癌的预后和免疫治疗反应。
Front Immunol. 2022 Sep 14;13:951455. doi: 10.3389/fimmu.2022.951455. eCollection 2022.
10
A prognostic model based on immune-related long noncoding RNAs for patients with epithelial ovarian cancer.基于免疫相关长非编码 RNA 的上皮性卵巢癌预后模型。
J Ovarian Res. 2022 Jan 15;15(1):8. doi: 10.1186/s13048-021-00930-w.

本文引用的文献

1
Sangerbox: A comprehensive, interaction-friendly clinical bioinformatics analysis platform.Sangerbox:一个全面的、用户交互友好的临床生物信息学分析平台。
Imeta. 2022 Jul 8;1(3):e36. doi: 10.1002/imt2.36. eCollection 2022 Sep.
2
Derivation and Validation of a Necroptosis-Related lncRNA Signature in Patients with Ovarian Cancer.卵巢癌患者中坏死性凋亡相关长链非编码RNA特征的推导与验证
J Oncol. 2022 May 23;2022:6228846. doi: 10.1155/2022/6228846. eCollection 2022.
3
Necroptosis-Associated lncRNA Prognostic Model and Clustering Analysis: Prognosis Prediction and Tumor-Infiltrating Lymphocytes in Breast Cancer.
坏死性凋亡相关长链非编码RNA预后模型与聚类分析:乳腺癌的预后预测及肿瘤浸润淋巴细胞
J Oncol. 2022 Apr 27;2022:7099930. doi: 10.1155/2022/7099930. eCollection 2022.
4
Cervical Carcinoma: Oncobiology and Biomarkers.宫颈癌:肿瘤生物学与生物标志物。
Int J Mol Sci. 2021 Nov 22;22(22):12571. doi: 10.3390/ijms222212571.
5
Establishment and experimental validation of an immune miRNA signature for assessing prognosis and immune landscape of patients with colorectal cancer.建立并验证免疫 miRNA 标志物用于评估结直肠癌患者的预后和免疫图谱
J Cell Mol Med. 2021 Jul;25(14):6874-6886. doi: 10.1111/jcmm.16696. Epub 2021 Jun 7.
6
PD-1/PD-L1 in Cancer: Pathophysiological, Diagnostic and Therapeutic Aspects.PD-1/PD-L1 在癌症中的作用:病理生理学、诊断和治疗方面。
Int J Mol Sci. 2021 May 12;22(10):5123. doi: 10.3390/ijms22105123.
7
NF-κB in Cancer Immunity: Friend or Foe?NF-κB 在癌症免疫中的作用:是敌是友?
Cells. 2021 Feb 9;10(2):355. doi: 10.3390/cells10020355.
8
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
9
NF-κB inhibitors in treatment and prevention of lung cancer.NF-κB 抑制剂在肺癌治疗和预防中的应用。
Biomed Pharmacother. 2020 Oct;130:110569. doi: 10.1016/j.biopha.2020.110569. Epub 2020 Aug 1.
10
Myeloid-Derived Suppressor Cells as a Therapeutic Target for Cancer.髓源性抑制细胞作为癌症治疗靶点。
Cells. 2020 Feb 27;9(3):561. doi: 10.3390/cells9030561.